Stokes et al. verified that pharmacological inhibition of FAK reduced TAMs within the tumor and reduced the size of the primary tumor in a pancreatic ductal adenocarcinoma mouse model [29]. Here, PTK2 is linked to pancreatic ductal adenocarcinoma.